Rodulfo Alejandro, Goldstein Sabina, Meriden Zina
Psychiatry, Memorial Regional Hospital, Hollywood, USA.
Cureus. 2023 Dec 6;15(12):e50063. doi: 10.7759/cureus.50063. eCollection 2023 Dec.
Antipsychotics are the mainstay for the treatment of schizophrenia and other psychotic disorders; however, these agents are associated with an extensive side effect profile that may complicate treatment outcomes. We present the case of a 35-year-old woman with a history of schizoaffective disorder and five prior psychiatric hospitalizations. The patient first presented to the hospital for disorganized behavior, in addition to poor sleep, auditory hallucinations, and racing thoughts in the context of medication nonadherence. She received two loading doses of intra-muscular paliperidone with fair symptomatic improvement. After discharge, she was scheduled to receive a monthly dose of paliperidone, which she missed, resulting in decompensation, re-emergence of psychosis, and another hospitalization two months later. She was given the missed dose with no improvement and progressive deterioration, for which alternative agents were tried. She received olanzapine and was tried briefly on quetiapine and haloperidol as well, with no benefit, and she also developed abnormal perioral movements. She was reloaded with paliperidone, and her psychotic symptoms improved, although she developed akathisia and hyperprolactinemia. The patient returned to the hospital two days later after being discharged, due to disorganized behavior and multiple delusions. Clozapine was started and titrated to 100 mg qam and 200 mg qhs. While on clozapine, she developed profuse sialorrhea that was treated with sublingual atropine drops, and by the time of discharge psychotic symptoms had markedly improved, perioral movements diminished, and prolactin level trended down. The patient maintained stability for over a year after the last admission. Identifying antipsychotics to successfully treat refractory psychosis and managing their multiple potential side effects is challenging but can result in better quality of life for patients as well as improved treatment adherence. This case report is unique in the way it illustrates this point, while discussing different approaches to managing multiple side effects that can happen simultaneously.
抗精神病药物是治疗精神分裂症和其他精神障碍的主要药物;然而,这些药物具有广泛的副作用,可能会使治疗结果复杂化。我们报告一例35岁女性,有分裂情感性障碍病史,曾5次入住精神病院。患者首次因行为紊乱、睡眠不佳、幻听和在不依从药物治疗情况下的思维奔逸而入院。她接受了两次肌内注射帕利哌酮负荷剂量,症状有一定改善。出院后,她原定每月接受一次帕利哌酮治疗,但她未按时服药,导致病情恶化,精神病症状复发,两个月后再次住院。她服用了漏服的剂量,但症状未改善且病情逐渐恶化,于是尝试了其他药物。她服用了奥氮平,还短期试用了喹硫平和氟哌啶醇,但均无效果,并且她还出现了口周异常运动。她再次服用帕利哌酮,精神病症状有所改善,尽管出现了静坐不能和高泌乳素血症。患者出院两天后因行为紊乱和多种妄想再次入院。开始使用氯氮平并滴定至每日上午100毫克、每晚200毫克。服用氯氮平时,她出现了大量流涎,用舌下含服阿托品滴剂治疗,出院时精神病症状明显改善,口周运动减少,泌乳素水平呈下降趋势。患者在最后一次入院后保持稳定状态超过一年。确定能成功治疗难治性精神病的抗精神病药物并管理其多种潜在副作用具有挑战性,但可为患者带来更好的生活质量并提高治疗依从性。本病例报告以独特的方式说明了这一点,同时讨论了管理可能同时发生的多种副作用的不同方法。